Display Settings:

Format

Send to:

Choose Destination
Vaccine. 2010 Aug 23;28(37):5952-9. doi: 10.1016/j.vaccine.2010.07.003. Epub 2010 Jul 8.

Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza.

Author information

  • 1Applied Modeling, Public Health Computational and Operations Research, University of Pittsburgh, Pittsburgh, PA 15213, USA. BYL1@pitt.edu

Abstract

Employers may be loath to fund vaccination programs without understanding the economic consequences. We developed a decision analytic computational simulation model including dynamic transmission elements that estimated the cost-benefit of employer-sponsored workplace vaccination from the employer's perspective. Implementing such programs was relatively inexpensive (<$35/vaccinated employee) and, in many cases, cost saving across diverse occupational groups in all seasonal influenza scenarios. Such programs were cost-saving for a 20% serologic attack rate pandemic scenario (range: -$15 to -$995) per vaccinated employee) and a 30% serologic attack rate pandemic scenario (range: -$39 to -$1,494 per vaccinated employee) across all age and major occupational groups.

Copyright 2010 Elsevier Ltd. All rights reserved.

PMID:
20620168
[PubMed - indexed for MEDLINE]
PMCID:
PMC2926133
Free PMC Article

Images from this publication.See all images (1)Free text

Figure 1
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk